Skip to main content
Premium Trial:

Request an Annual Quote

Everyone Wants to Sequence

With rapid changes to sequencing technology, Dan Koboldt at MassGenomics says that "genomes abound" and that "everyone wants to sequence," though not every lab can afford its own sequencer. Enter sequence service providers such as BGI and Complete Genomics. "These new sequencers and service providers are going to put high-throughput sequencing into the hands of many investigators. Investigators, I might add, who likely have never dealt with NGS data," Koboldt writes. "I think that's potentially very exciting, and I hope that the experiences of major genome centers will help newcomers address the challenges of massively parallel sequencing.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.